Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic, shared a post on X about a recent paper by A. Bercz et al. published in Annals of Clinical Oncology.
Authors: A. Bercz, B.K. Park, E. Pappou, J.J. Smith, P.B. Romesser et al.
“LC-CRT vs. SC-RT for Rectal Cancer Organ Preservation
MSKCC SOC: LC-CRT TNT, during COVID shifted to SC-RT
Study demonstrated:
- cCR rates (~ 40%)
- OS and DFS
- Regrowth Organ Preservation with LC-CRT
Suggests LC-CRT preferred for NOM
German AIO-18 to clarify.”
Source: Krishan Jethwa/X
